CoChat
Sign Up
Cited by 79

The DOI matches its Crossref record.

Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: In vitro skin penetration studies and antifungal efficacy using Candida albicans as model

Alomrani, Abdullah H., Shazly, Gamal A., Amara, Amro A., Badran, Mohamed M.·2014·Colloids and Surfaces B: Biointerfaces
DOI 10.1016/j.colsurfb.2014.05.030
Open this paper in CoChat — free account

Abstract

The study aimed to develop novel ITZ-loaded deformable liposomes (DL) in presence of hydroxypropyl-β-cyclodextrin (HPβCD) (DL-CD) to enhance antifungal activity. These formulations have been reported as conceivable vesicles to deliver drug molecules to the skin layers. The efficiency of the prepared systems was compared with conventional liposomes (CL) and ITZ solution. The developed liposomes were characterized for particle size, entrapment efficiency (EE %), deformability, stability, and morphology of the vesicles. In addition, ex vivo penetration and antifungal activity were evaluated. It was found that the presence of HPβCD played a significant role in reducing the vesicle size to nano range. The deformability study and TEM images revealed that membrane deformability of DL and DL-CD was much higher than that of CL. Moreover, DL-CD enhanced the amount of ITZ in SC and deeper skin layers compared to DL and CL. The antifungal activity of ITZ-loaded deformable liposomes remained intact compared to ITZ solution. It can be concluded that deformable liposomes in the presence of HPβCD may be a promising carrier for effective cutaneous delivery of ITZ.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.colsurfb.2014.05.030

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Zheng, 2012, Preparation and quality assessment of itraconazole transfersomes, Int. J. Pharm., 436, 291, 10.1016/j.ijpharm.2012.07.003 · DOI
  2. Gillet, 2011, Skin penetration behaviour of liposomes as a function of their composition, Eur. J. Pharm. Pharm. Biopharm., 79, 43, 10.1016/j.ejpb.2011.01.011 · DOI
  3. Cevc, 2004, Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage, Biochim. Biophys. Acta, 1663, 61, 10.1016/j.bbamem.2004.01.006 · DOI
  4. Elsayed, 2007, Lipid vesicles for skin delivery of drugs: reviewing three decades of research, Int. J. Pharm., 332, 1, 10.1016/j.ijpharm.2006.12.005 · DOI
  5. Song, 2012, A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation, Colloids Surf. B: Biointerfaces, 92, 299, 10.1016/j.colsurfb.2011.12.004 · DOI
  6. Dragicevic-Curic, 2009, Development of liposomes containing ethanol for skin delivery of temoporfin: characterization and in vitro penetration studies, Colloids Surf. B: Biointerfaces, 74, 114, 10.1016/j.colsurfb.2009.07.005 · DOI
  7. Maestrellia, 2010, New drug-in cyclodextrin-in deformable liposomes formulations to improve the therapeutic efficacy of local anaesthetics, Int. J. Pharm., 395, 222, 10.1016/j.ijpharm.2010.05.046 · DOI
  8. Loftsson, 2001, Cyclodextrins in topical drug formulations: theory and practice, Int. J. Pharm., 225, 15, 10.1016/S0378-5173(01)00761-X · DOI
  9. Loftsson, 2011, Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes, J. Pharm. Pharmacol., 63, 1119, 10.1111/j.2042-7158.2011.01279.x · DOI
  10. Peeters, 2002, Characterization of the interaction of 2-hydroxypropyl-bcyclodextrin with itraconazole at pH 2, 4, and 7, J. Pharm. Sci., 91, 1414, 10.1002/jps.10126 · DOI
  11. Yang, 2010, In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution, Eur. J. Pharm. Sci., 39, 336, 10.1016/j.ejps.2010.01.001 · DOI
  12. Elhissi, 2012, Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients, Int. J. Pharm., 436, 519, 10.1016/j.ijpharm.2012.06.064 · DOI
  13. de Chasteigner, 1996, Comparative study of the association of itraconazole with colloidal drug carriers, Drug Dev. Res., 38, 125, 10.1002/(SICI)1098-2299(199606)38:2<125::AID-DDR7>3.0.CO;2-L · DOI
  14. Aggarwal, 2012, Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis-Dermatophytosis, Int. J. Pharm., 437, 277, 10.1016/j.ijpharm.2012.08.015 · DOI
  15. Nasr, 2008, Vesicular aceclofenac systems: a comparative study between liposomes and niosomes, J. Microencapsul., 25, 499, 10.1080/02652040802055411 · DOI
  16. Hiruta, 2006, Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin, J. Control. Release, 113, 146, 10.1016/j.jconrel.2006.04.016 · DOI
  17. Fan, 2009, Determination of itraconazole in human plasma by HPLC, Northwest Chin. J. Pharm. Sci., 24, 86
  18. Zhu, 2006, HPLC determination of aqueous humor levels of itraconazole, J. Jining Med. Coll., 29, 36
  19. Santosh, 2012, Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma, Nanomed. Nanotechnol. Biol. Med., 8, 440, 10.1016/j.nano.2011.07.011 · DOI
  20. Azarbayjani, 2009, Impact of surface tension in pharmaceutical sciences, J. Pharm. Pharm. Sci., 12, 218, 10.18433/J32P40 · DOI
  21. Van Santvliet, 1998, The influence of penetration enhancers on the volume instilled of eye drops, Eur. J. Pharm. Biopharm., 45, 189, 10.1016/S0939-6411(97)00114-8 · DOI
  22. Chen, 2010, Skin delivery of ferulic acid from different vesicular systems, J. Biomed. Nanotechnol., 6, 577, 10.1166/jbn.2010.1154 · DOI
  23. Essa, 2002, Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes, Int. J. Pharm., 24, 55, 10.1016/S0378-5173(02)00107-2 · DOI
  24. Marzio, 2013, Polysorbate 20 vesicles as oral delivery system: in vitro characterization, Colloids Surf. B: Biointerfaces, 104, 200, 10.1016/j.colsurfb.2012.10.036 · DOI
  25. Essa, 2004, Electrically assisted skin delivery of liposomal estradiol: phospholipid as damage retardant, J. Control. Release, 95, 535, 10.1016/j.jconrel.2003.12.015 · DOI
  26. Guan, 2011, Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt, Int. J. Nanomed., 6, 965
  27. El Zaafarany, 2010, Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery, Int. J. Pharm., 397, 164, 10.1016/j.ijpharm.2010.06.034 · DOI · Paper page
  28. Verma, 2003, Particle size of liposomes influences dermal delivery of substances into skin, Int. J. Pharm., 258, 141, 10.1016/S0378-5173(03)00183-2 · DOI
  29. Kapoor, 2011, Formulation development and characterization of itraconazole granules, Int. J. Pharm. Sci. Nanotechnol., 4, 1497
  30. Pabyton, 2013, Nanoencapsulation of quercetin and resveratrol into elastic liposomes, Biochim. Biophys. Acta, 1828, 309, 10.1016/j.bbamem.2012.10.022 · DOI
  31. El Maghraby, 2006, Can drug-bearing liposomes penetrate intact skin?, J. Pharm. Pharmacol., 58, 415, 10.1211/jpp.58.4.0001 · DOI
  32. El Maghraby, 2000, Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration, Int. J. Pharm., 196, 63, 10.1016/S0378-5173(99)00441-X · DOI
  33. Monteiro, 2012, Evaluation of octyl p-methoxycinnamate included in liposomes and cyclodextrins in anti-solar preparations: preparations, characterizations and in vitro penetration studies, Int. J. Nanomed., 7, 3045
  34. Monti, 2011, Permeation and distribution of ferulic acid and its α-cyclodextrin complex from different formulations in hairless rat skin, AAPS PharmSciTech, 12, 514, 10.1208/s12249-011-9609-y · DOI
  35. Sanjay, 2008, Elastic liposomes bearing meloxicam-β-cyclodextrin for transdermal delivery, Curr. Drug Deliv., 8, 207
  36. Kaur, 2010, Drug-cyclodextrin-vesicles dual carrier approach for skin targeting anti-acne agent, AAPS PharmSciTech, 11, 529, 10.1208/s12249-010-9411-2 · DOI
  37. Kear, 2008, Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery, Drug Dev. Ind. Pharm., 34, 692, 10.1080/03639040701842428 · DOI
  38. Ventura, 2006, Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin, Int. J. Pharm., 314, 37, 10.1016/j.ijpharm.2006.02.006 · DOI

Cited by

Sorted by citations

Metadata

Authors
Alomrani, A. H., Shazly, G. A., Amara, A. A., & Badran, M. M.
ORCID
Venue
Colloids and Surfaces B: Biointerfaces
Publisher
Elsevier BV
Published
2014-09
Volume
121
Pages
74-81
ISSN
0927-7765
DOI
10.1016/j.colsurfb.2014.05.030
Cited by
79
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
King Saud University (RGP-VPP-287)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review